PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 72 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $13,000 | -91.7% | 20,834 | -91.3% | 0.00% | -100.0% |
| Q1 2017 | $156,000 | +2128.6% | 238,906 | +941.5% | 0.00% | – |
| Q4 2016 | $7,000 | -70.8% | 22,939 | -58.8% | 0.00% | -100.0% |
| Q3 2016 | $24,000 | 0.0% | 55,728 | -14.0% | 0.00% | – |
| Q2 2016 | $24,000 | -70.4% | 64,786 | -6.0% | 0.00% | -100.0% |
| Q4 2015 | $81,000 | -15.6% | 68,901 | -6.4% | 0.00% | -50.0% |
| Q2 2015 | $96,000 | +336.4% | 73,585 | +356.7% | 0.00% | – |
| Q1 2015 | $22,000 | -62.7% | 16,112 | -62.0% | 0.00% | -100.0% |
| Q4 2014 | $59,000 | -49.1% | 42,360 | -50.3% | 0.00% | -50.0% |
| Q3 2014 | $116,000 | +123.1% | 85,152 | +208.7% | 0.00% | +100.0% |
| Q2 2014 | $52,000 | -61.8% | 27,581 | -61.8% | 0.00% | -50.0% |
| Q1 2014 | $136,000 | +7.1% | 72,162 | -21.2% | 0.00% | +100.0% |
| Q4 2013 | $127,000 | +39.6% | 91,568 | +40.1% | 0.00% | 0.0% |
| Q3 2013 | $91,000 | – | 65,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 148,006 | $206,000 | 0.10% |
| First Heartland Consultants, Inc. | 86,204 | $120,000 | 0.07% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 671,900 | $934,000 | 0.02% |
| Investors Capital Advisory Services | 47,238 | $65,000 | 0.02% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $28,000 | 0.01% |
| Commonwealth Equity Services, Inc | 481,140 | $669,000 | 0.01% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 11,300 | $16,000 | 0.01% |
| First Allied Advisory Services, Inc. | 50,000 | $70,000 | 0.01% |
| Winslow, Evans & Crocker, Inc. | 13,200 | $18,000 | 0.01% |
| AMALGAMATED BANK | 16,650 | $23,000 | 0.00% |